
GSK plc
GSKHealthcare · Stock · quarterly payer
Forward Yield
3.50%
Annual Dividend
$1.80
Payout Ratio
47%
5-Yr Growth
-4.0%
Ex-Date
May 15, 2026
Frequency
Quarterly
Summary
As of July 2026, GSK plc (GSK) yields 3.50% ($1.80 per share annually), with a blended fair-value estimate of $56.55 — +10% upside, so it screens as fairly valued. Dividend safety grade: C (54/100). 2 years of dividend growth.
Is GSK a good dividend stock?
MixedGSK plc (GSK) pays a quarterly dividend yielding 3.50% ($1.80/yr), with 2 years of growth and a dividend-safety grade of C. The picture is mixed — the dividend pays, but safety or growth signals are weaker than ideal.
Advantages
- Comfortable payout ratio (47%)
Risks
- Cut its dividend in 2023
- Dividend has been shrinking, not growing
Key Data
- Dividend Yield
- 3.50%
- Payout Ratio
- 47%
- Annual Dividend
- $1.80
- 5-Yr Avg Growth
- -4.0%
- Ex-Dividend Date
- May 15, 2026
- Years of Growth
- 2
- Frequency
- quarterly
- Beta
- 0.30
- Market Cap
- $102.8B
- P/E Ratio
- 13.5
- 5-Yr Total Return
- 26%
- 52-Week Range
- $36.75 – $61.70
- Dividend Safety
- C · 54/100
- Ever Cut?
- Yes (2023)
Frequently Asked Questions
GSK Price — Last 12 Months
Daily close
Price Return
1 Year
+29%
3 Years
+46%
5 Years
+26%
52-Week Range
$36.75 – $61.70
Price change over each period (excludes dividends). Past performance doesn't guarantee future results.
What is GSK worth?
Fairly valuedhigh confidenceOur blended fair-value estimate for GSK plc is $56.55 per share, versus a market price of $51.35. That implies the stock is roughly fairly priced.
Fair Value
$56.55
Current Price
$51.35
Gap
+10%
Margin of Safety
9%
How we get there
Discounted cash flow
Discounts projected free cash flow back to today.
Dividend discount
Discounts the future dividend stream back to today.
Earnings multiple (Graham)
Graham's earnings-multiple formula, anchored to bond yields.
At today's price, the market is pricing in about 2.4% annual free-cash-flow growth. We model 5.1% — below our estimate, leaving room for upside if the business executes.
Assumptions: 7.0% discount rate (CAPM), 5.1% stage-1 growth, 2.5% terminal growth, $3.80 EPS, $1.80 annual dividend. Updated weekly.
Fair-value estimates are model output for educational purposes only — not investment advice or a price target.
GSK Dividend Safety Score
Borderline
SmarterDividends' proprietary score, backtested against which dividends were actually cut over 15+ years (0.78 AUC). It blends a validated cut-risk model (growth streak, cut history) with current payout, cash-flow and debt. Higher is safer · not investment advice.
Dividend Growth
Total dividends per share by year
Dividend History
| Ex-Date | Pay Date | Amount | Type |
|---|---|---|---|
| May 15, 2026 | — | $0.4610 | regular |
| Feb 20, 2026 | — | $0.4860 | regular |
| Nov 14, 2025 | — | $0.4170 | regular |
| Aug 15, 2025 | — | $0.4280 | regular |
| May 16, 2025 | — | $0.4290 | regular |
| Feb 21, 2025 | — | $0.4010 | regular |
| Nov 15, 2024 | — | $0.3890 | regular |
| Aug 16, 2024 | — | $0.3860 | regular |
| May 16, 2024 | — | $0.3760 | regular |
| Feb 22, 2024 | — | $0.4060 | regular |
| Nov 16, 2023 | — | $0.3400 | regular |
| Aug 17, 2023 | — | $0.3610 | regular |
| May 18, 2023 | — | $0.3480 | regular |
| Feb 23, 2023 | — | $0.3400 | regular |
Income Calculator
At $1.80 / yr per share




